
ACTIVE WATCHFUL WAITING
Safeguarding children from institutional harm
Systematic omission creates misleading overall impression
When Kaleido's Gender Affirmation, GP Services, Child/Family/Youth, Mental Health, Q&A, Home, and Book Now pages are read together, they create a misleading overall impression. Prominent benefit-oriented language appears throughout, while material risks, evidence limitations, eligibility restrictions, minor-specific safeguards, fertility implications, irreversibility, alternatives, and treatment progression information are systematically omitted.
Key evidence
Present throughout the website:
-
"Safe," "best-practice," "evidence-based," "developmentally appropriate" claims
-
Benefit-oriented framing with no qualifying information
-
Reassurance language about mental health outcomes
Systematically absent:
-
Material risks (cardiovascular, bone health, fertility, sexual function)
-
Evidence quality limitations (low/very-low certainty)
-
Irreversibility of certain effects
-
Minor-specific safeguards (parental consent, court authorisation)
-
Alternative approaches (watchful waiting, psychological support)
-
Treatment pathway progression rates (~95% blockers → hormones)
This systematic imbalance - prominent benefits with zero material caveats - creates a misleading overall impression.
The legal issue
Section 133(1)(a) of the Health Practitioner Regulation National Law prohibits advertising that is false, misleading, or deceptive. The clinic's website is advertising: it makes treatment claims to attract consumers.
When benefit language is prominent and material information is systematically absent, the overall impression is misleading even if no single statement is technically false. Australian Consumer Law sections 18 and 29 apply the same standard: representations can mislead through omission of material information.
AHPRA Finding 1 audit report and ACL audit report 'Overall assessment' document this systematic omission as the foundational compliance failure.
Evidence detail
AHPRA Advertising Standard for Medical Website Compliance: Under AHPRA's advertising framework, a medical website is not compliant merely because it avoids obvious falsehoods; it must avoid misleading overall impressions created by omission, selective evidence, minimised risks, unqualified benefit claims, testimonials, urgency framing, or unsupported claims likely to influence healthcare decisions. AHPRA Guidelines state: “4.1 False, misleading or deceptive advertising 133 (1) A person must not advertise a regulated health service, or a business that provides a regulated health service, in a way that— (a) is false, misleading or deceptive or is likely to be misleading or deceptive"
Assessment criteria The audit assessed the clinic's website against Australian Consumer law (ACL) and the National Law section 133, FINDINGS: 1. Material age eligibility information hidden on Q&A page not accessible via standard navigation; service pages provide no age limits, eligibility criteria, or exclusion information (ACL s18, s29(1)(g), s29(1)(l)) 2. Unqualified 'evidence-based care' claim without disclosure of evidence uncertainty documented in independent systematic reviews (ACL s18) 3. Strong benefit claims ("safe", "evidence-based") with no mention of uncertainty, evidence limits, or the contested nature of the evidence base. (ACL s18) 4. Complete absence of risk disclosure despite offering hormone therapy (ACL s18, s29(1)(g)) 5. No disclosure of irreversible effects (ACL s18, s29(1)(g)) 6. Fertility impact not disclosed. Fertility preservation listed as unavailable future service; no warning that current hormone therapy may impair fertility (ACL s18, s29(1)(g)) 7. No discussion of non-medical alternatives (watchful waiting, psychological support as standalone pathways) (ACL s18) 8. No disclosure of high progression rates from initial intervention to irreversible medical pathway (ACL s18, s29(1)(g)) 9. Authority substitution: AusPATH alignment claimed as evidence of quality without disclosing that AusPATH Guidelines scored 19% on rigorous evidence grading and is under review for replacement (ACL s18) 10. Minors possibly in scope, no consent process visible. Clinic confirms it treats minors via hidden Q&A page, paediatric referrals listed; but provides zero minor-specific information on service pages: no parental consent requirements, no age-differentiated protocols, no court dispute processes (ACL s18, s29(1)(g)) 11. Claim of 'developmentally appropriate' care for all ages without disclosure of what age-differentiated assessment or treatment protocols exist (ACL s18, s29(1)(l)) 4.1 False, misleading or deceptive advertising1 133 (1) A person must not advertise a regulated health service, or a business that provides a regulated health service, in a way that— (a) is false, misleading or deceptive or is likely to be misleading or deceptive.
For Parents
What this means for you
You're seeing only the benefits, never the risks. That's not informed consent - that's marketing. Before you make any decisions, you need to know what the clinic isn't telling you.
For Mps
Policy & regulatory issue
This is the core AWW's AHPRA complaint. Every other finding (unqualified claims, missing risks, hidden eligibility rules) flows from this systematic pattern.
For Health Professionals
Clinical & professional standards issue
Professional standards require balanced disclosure. When a clinic systematically presents benefits while omitting material harms, patients cannot arrive at consultations with genuinely informed expectations. The public website undermines the consent process before it begins.
Evidence detail
This systematic omission manifests across specific domains:
Finding 2: Unqualified Claims — "Safe" and "evidence-based" without caveats
Finding 3: Risk Disclosure — Zero mention of material harms
Finding 4: Minors & Safeguards — Hidden eligibility and legal requirements